Issue navigation
Volume 110, Issue 11, November 2018
Editorials
Lung Cancer Screening and Smoking Cessation: Never Too Early or Too Late
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 11, November 2018, Pages 1157–1158, https://doi.org/10.1093/jnci/djy083
Reduced Risk of Prostate Cancer With 5α-Reductase Inhibitors
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 11, November 2018, Pages 1159–1160, https://doi.org/10.1093/jnci/djy038
Novel Insights Into the Impact of Lifestyle-Based Weight Loss and Metformin on Obesity-Associated Biomarkers in Breast Cancer
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 11, November 2018, Pages 1161–1162, https://doi.org/10.1093/jnci/djy080
Commentary
Expanding the Evidence Base in Geriatric Oncology: Action Items From an FDA-ASCO Workshop
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 11, November 2018, Pages 1163–1170, https://doi.org/10.1093/jnci/djy169
Effect Sizes of Somatic Mutations in Cancer
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 11, November 2018, Pages 1171–1177, https://doi.org/10.1093/jnci/djy168
Reviews
BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-analysis
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 11, November 2018, Pages 1178–1189, https://doi.org/10.1093/jnci/djy148
Targeting Exercise Interventions to Patients With Cancer in Need: An Individual Patient Data Meta-Analysis
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 11, November 2018, Pages 1190–1200, https://doi.org/10.1093/jnci/djy161
Articles
Lifetime Smoking History and Risk of Lung Cancer: Results From the Framingham Heart Study
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 11, November 2018, Pages 1201–1207, https://doi.org/10.1093/jnci/djy041
Using Medicare Claims to Examine Long-term Prostate Cancer Risk of Finasteride in the Prostate Cancer Prevention Trial
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 11, November 2018, Pages 1208–1215, https://doi.org/10.1093/jnci/djy035
Risk of Prostate Cancer in Men Treated With 5α-Reductase Inhibitors—A Large Population-Based Prospective Study
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 11, November 2018, Pages 1216–1221, https://doi.org/10.1093/jnci/djy036
Automated Cervical Screening and Triage, Based on HPV Testing and Computer-Interpreted Cytology
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 11, November 2018, Pages 1222–1228, https://doi.org/10.1093/jnci/djy044
Effects of Nutrition Intervention on Total and Cancer Mortality: 25-Year Post-trial Follow-up of the 5.25-Year Linxian Nutrition Intervention Trial
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 11, November 2018, Pages 1229–1238, https://doi.org/10.1093/jnci/djy043
The Effects of Metformin and Weight Loss on Biomarkers Associated With Breast Cancer Outcomes
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 11, November 2018, Pages 1239–1247, https://doi.org/10.1093/jnci/djy040
Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 11, November 2018, Pages 1248–1258, https://doi.org/10.1093/jnci/djy052
Striking Racial/Ethnic Disparities in Liver Cancer Incidence Rates and Temporal Trends in California, 1988–2012
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 11, November 2018, Pages 1259–1269, https://doi.org/10.1093/jnci/djy051
Brief Communication
Black–White Breast Cancer Incidence Trends: Effects of Ethnicity
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 11, November 2018, Pages 1270–1272, https://doi.org/10.1093/jnci/djy112
Correspondence
RE: Elevated Bladder Cancer in Northern New England: The Role of Drinking Water and Arsenic
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 11, November 2018, Pages 1273–1274, https://doi.org/10.1093/jnci/djy045
RE: The Rise of Radiomics and Implications for Oncologic Management
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 11, November 2018, Pages 1275–1276, https://doi.org/10.1093/jnci/djy037
RE: Familial Cancer Clustering of Urothelial Cancer: A Population-Based Case–Control Study
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 11, November 2018, Pages 1277–1278, https://doi.org/10.1093/jnci/djy053
Response to K. Hemminki et al.
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 11, November 2018, Page 1279, https://doi.org/10.1093/jnci/djy054
RE: Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysis
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 11, November 2018, Pages 1280–1281, https://doi.org/10.1093/jnci/djy046
Response to A. Matikas et al.
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 11, November 2018, Pages 1282–1283, https://doi.org/10.1093/jnci/djy048
